PE20030692A1 - Agentes antidisritmicos administrados vaginalmente para tratar el dolor pelvico - Google Patents
Agentes antidisritmicos administrados vaginalmente para tratar el dolor pelvicoInfo
- Publication number
- PE20030692A1 PE20030692A1 PE2002001058A PE2002001058A PE20030692A1 PE 20030692 A1 PE20030692 A1 PE 20030692A1 PE 2002001058 A PE2002001058 A PE 2002001058A PE 2002001058 A PE2002001058 A PE 2002001058A PE 20030692 A1 PE20030692 A1 PE 20030692A1
- Authority
- PE
- Peru
- Prior art keywords
- bioadhesive
- pelvic pain
- composition
- polymeroxyl
- polymero
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Pregnancy & Childbirth (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
SE REFIERE A UNA COMPOSICION VAGINAL QUE COMPRENDE: a) UN AGENTE DE TRATAMIENTO ANTIDISRITMICO SELECCIONADO DE UN ANTIRRITMICO CORONARIO, ANESTESICOS LOCALES, BLOQUEADOR DEL CANAL DE CALCIO, AGENTES AUTOCOIDES, BLOQUEADORES DE PROSTAGLANDINAS, ENTRE OTROS TALES COMO CLORPROCAINA, LIDOCAINA, TETRACAINA, BUPIVACAINA, BENZOCAINA, PROPAFENONA, AMIODARONA, VERAPAMIL, DIGOXINA, DILTIAZEM, CELECOXIB, ROFECOXIB, ENTRE OTROS Y b) UN PORTADOR BIOADHESIVO DE LIBERACION PROLONGADA FARMACEUTICAMENTE ACEPTABLE SELECCIONADA DE POLIMERO DEL ACIDO POLICARBOXILICO ENTRECRUZADO, BIOADHESIVO, INSOLUBLE EN AGUA COMO POLICARBOFILO QUE LIBERA EL AGENTE DE TRATAMIENTO DE DURANTE UN PERIODO DE TIEMPO PROLONGADO DESPUES DE LA ADMINISTRACION. LA COMPOSICION CONTIENE DE 2% A 10% EN PESO DE LIDOCAINA. LA COMPOSICION ES UTIL PARA EL TRATAMIENTO DEL DOLOR PELVICO Y TRATAR LA INFERTILIDAD
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33068401P | 2001-10-29 | 2001-10-29 | |
US10/278,912 US20030114394A1 (en) | 2001-10-29 | 2002-10-24 | Vaginally administered anti-dysrhythmic agents for treating pelvic pain |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20030692A1 true PE20030692A1 (es) | 2003-08-28 |
Family
ID=26959337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2002001058A PE20030692A1 (es) | 2001-10-29 | 2002-10-28 | Agentes antidisritmicos administrados vaginalmente para tratar el dolor pelvico |
Country Status (34)
Country | Link |
---|---|
US (1) | US20030114394A1 (es) |
EP (2) | EP1441770B1 (es) |
JP (2) | JP2005511564A (es) |
KR (2) | KR20050040820A (es) |
CN (1) | CN100404072C (es) |
AR (1) | AR037048A1 (es) |
AT (2) | ATE451123T1 (es) |
AU (1) | AU2002350644B2 (es) |
BR (1) | BR0213585A (es) |
CA (1) | CA2465132C (es) |
CY (2) | CY1106000T1 (es) |
DE (2) | DE60216495T2 (es) |
DK (2) | DK1764111T3 (es) |
ES (2) | ES2336238T3 (es) |
GE (1) | GEP20094614B (es) |
HK (2) | HK1063293A1 (es) |
HR (1) | HRP20040479B1 (es) |
HU (1) | HUP0402389A3 (es) |
IL (3) | IL161513A0 (es) |
MA (1) | MA26230A1 (es) |
ME (1) | ME00255B (es) |
MX (1) | MXPA04003976A (es) |
MY (2) | MY149482A (es) |
NO (1) | NO333544B1 (es) |
NZ (1) | NZ532295A (es) |
PE (1) | PE20030692A1 (es) |
PL (2) | PL369790A1 (es) |
PT (2) | PT1441770E (es) |
RS (1) | RS51414B (es) |
RU (2) | RU2476212C2 (es) |
SI (2) | SI1441770T1 (es) |
UA (1) | UA90077C2 (es) |
WO (1) | WO2003037381A1 (es) |
ZA (1) | ZA200402944B (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7341737B2 (en) * | 1997-06-11 | 2008-03-11 | Kimberly-Clark Worldwide, Inc. | Medicated tampon |
US7344732B2 (en) * | 2002-01-10 | 2008-03-18 | Kimberly-Clark Worldwide, Inc. | Medicated tampon |
CH697081A5 (de) * | 2002-01-22 | 2008-04-30 | Andreas F Dr Schaub | Zusammensetzung für die Unterstützung der Geburt eines menschlichen Föten. |
US20050244402A1 (en) * | 2004-04-30 | 2005-11-03 | Villanueva Julie M | Absorption of pain-causing agents |
DE102004054552A1 (de) * | 2004-11-11 | 2006-05-18 | Hcb Happy Child Birth Holding Ag | Neue Zusammensetzung zur Erleichterung der Humangeburt |
US7919453B2 (en) | 2005-03-25 | 2011-04-05 | Kimberly-Clark Worldwide, Inc. | Dosage cap assembly for an applicator |
US7993667B2 (en) | 2005-03-25 | 2011-08-09 | Kimberly-Clark Worldwide, Inc. | Methods of manufacturing a medicated tampon assembly |
US7744556B2 (en) | 2005-03-25 | 2010-06-29 | Kimberly-Clark Worldwide, Inc. | Delivery tube assembly for an applicator |
US7708726B2 (en) | 2005-04-28 | 2010-05-04 | Kimberly-Clark Worldwide, Inc. | Dosage form cap for an applicator |
US20070253994A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Intraspinal Drug Delivery Methods and Devices To Alleviate Chronic Pelvic Pain |
US20080108824A1 (en) * | 2006-09-28 | 2008-05-08 | Med Institute, Inc | Medical Devices Incorporating a Bioactive and Methods of Preparing Such Devices |
WO2008039995A2 (en) * | 2006-09-28 | 2008-04-03 | Vance Products Incorporated, D/Ba Cook Urological Incorporated | Medical device including a bioactive in a non-ionic and an ionic form and methods of preparation thereof |
WO2008042227A1 (en) * | 2006-09-28 | 2008-04-10 | Med Institute, Inc. | Medical device including an anesthetic and method of preparation thereof |
CN105581976A (zh) * | 2007-06-26 | 2016-05-18 | 沃纳奇尔科特有限责任公司 | 用于递送大分子和水溶性药物的阴道内药物递送装置 |
US8956642B2 (en) * | 2008-04-18 | 2015-02-17 | Medtronic, Inc. | Bupivacaine formulation in a polyorthoester carrier |
US8475823B2 (en) * | 2008-04-18 | 2013-07-02 | Medtronic, Inc. | Baclofen formulation in a polyorthoester carrier |
AU2009242127B2 (en) * | 2008-04-29 | 2014-03-27 | Pharnext | New therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of cell stress response |
BRPI0803568B8 (pt) * | 2008-08-14 | 2021-05-25 | Biolab San Us Farm Ltda | composição mucoaderente |
RU2538674C2 (ru) * | 2012-09-10 | 2015-01-10 | Открытое акционерное общество "Всероссийский научный центр по безопасности биологически активных веществ" (ОАО "ВНЦ БАВ") | Фармацевтическая композиция, обладающая пролонгированной противоаритмической активностью |
WO2015051336A1 (en) | 2013-10-03 | 2015-04-09 | David Wise | Compositions and methods for treating pelvic pain and other conditions |
JP6654057B2 (ja) * | 2016-02-10 | 2020-02-26 | 国立大学法人 筑波大学 | 局所麻酔薬を含有するポリイオンコンプレックスを有効成分とする局所疼痛制御用組成物 |
WO2017165707A1 (en) * | 2016-03-24 | 2017-09-28 | Juniper Pharmaceuticals, Inc. | Vaginal administration of agents for treating and preventing pain associated with gynecological medical procedures |
BR102018008324A2 (pt) * | 2018-04-25 | 2019-11-05 | Laboratorios Ferring Ltda | composição farmacêutica de uso tópico e processo de fabricação de composição farmacêutica de uso tópico |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3387419A (en) * | 1965-10-22 | 1968-06-11 | Kamberg Henry | Decking with trim strip |
EP0501523B1 (en) * | 1983-11-14 | 1997-04-09 | Columbia Laboratories, Inc. | Bioadhesive compositions |
US5234957A (en) * | 1991-02-27 | 1993-08-10 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
US5446070A (en) * | 1991-02-27 | 1995-08-29 | Nover Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
US5387419A (en) * | 1988-03-31 | 1995-02-07 | The University Of Michigan | System for controlled release of antiarrhythmic agents |
ES2084709T3 (es) * | 1989-11-03 | 1996-05-16 | Riker Laboratories Inc | Composicion bioadhesiva y parche. |
US5332576A (en) * | 1991-02-27 | 1994-07-26 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
IT1250421B (it) * | 1991-05-30 | 1995-04-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive. |
US5700485A (en) * | 1992-09-10 | 1997-12-23 | Children's Medical Center Corporation | Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid |
US5508045A (en) * | 1992-10-09 | 1996-04-16 | The Regents Of The University Of California | Method and agents for control and management of labor during pregnancy |
US5543150A (en) * | 1993-09-15 | 1996-08-06 | Columbia Laboratories, Inc. | Method of progesterone delivery and affect thereof |
US5667492A (en) * | 1994-10-07 | 1997-09-16 | Columbia Laboratories, Inc. | Use and composition of an anti-sexually transmitted diseases formulation |
GB9610359D0 (en) * | 1996-05-17 | 1996-07-24 | Edko Trading Representation | Pharmaceutical compositions |
US5663492A (en) * | 1996-06-05 | 1997-09-02 | Alapati; Rama Rao | System for continuous analysis and modification of characteristics of a liquid hydrocarbon stream |
US5985861A (en) * | 1996-11-04 | 1999-11-16 | Columbia Laboratories, Inc. | Progesterone for treating or reducing ischemia |
US5993856A (en) * | 1997-01-24 | 1999-11-30 | Femmepharma | Pharmaceutical preparations and methods for their administration |
US5977143A (en) * | 1997-02-15 | 1999-11-02 | Edelstam; Greta | Medicament against infertility which reduces phagocytosis of spermatozoa in women |
US6210710B1 (en) * | 1997-04-28 | 2001-04-03 | Hercules Incorporated | Sustained release polymer blend for pharmaceutical applications |
CA2207227A1 (en) * | 1997-06-09 | 1998-12-09 | Johnson & Johnson Inc. | Plant seed germination mat |
US6197327B1 (en) * | 1997-06-11 | 2001-03-06 | Umd, Inc. | Device and method for treatment of dysmenorrhea |
US5989535A (en) * | 1997-08-15 | 1999-11-23 | Soma Technologies | Polymeric bioadhesive emulsions and suspensions and methods of treatment |
US6248358B1 (en) * | 1998-08-25 | 2001-06-19 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets and methods of making and using the same |
DE69819748T2 (de) * | 1997-09-12 | 2004-09-30 | Columbia Laboratories (Bermuda) Ltd. | Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen |
AU750809B2 (en) * | 1997-09-26 | 2002-07-25 | Noven Pharmaceuticals, Inc. | Bioadhesive compositions and methods for topical administration of active agents |
US6135153A (en) * | 1998-01-02 | 2000-10-24 | Cleland, Sr. John | Anesthesia delivery systems and methods |
WO1999057303A1 (en) * | 1998-05-07 | 1999-11-11 | University Of Maryland, Baltimore | A method for diagnosing and treating chronic pelvic pain syndrome |
US6207696B1 (en) * | 1998-09-15 | 2001-03-27 | Cytos Pharamaceuticals, Llc | Compositions and methods for the prophylaxis and treatment of dysmenorrhea, endometriosis, and pre-term labor, using histidine |
US6486207B2 (en) * | 1998-12-10 | 2002-11-26 | Nexmed (Holdings), Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
US6264973B1 (en) * | 1999-08-26 | 2001-07-24 | Fei Enterprises, Ltd. | Apparatus and method for anesthetizing the cervical region of a female |
AU7331300A (en) * | 1999-08-27 | 2001-03-26 | Merck & Co., Inc. | Method for treating or preventing chronic prostatitis or chronic pelvic pain syndrome |
US20020013331A1 (en) * | 2000-06-26 | 2002-01-31 | Williams Robert O. | Methods and compositions for treating pain of the mucous membrane |
-
2002
- 2002-10-24 US US10/278,912 patent/US20030114394A1/en not_active Abandoned
- 2002-10-28 WO PCT/EP2002/012042 patent/WO2003037381A1/en active Application Filing
- 2002-10-28 RS YUP-367/04A patent/RS51414B/en unknown
- 2002-10-28 GE GEAP20028235A patent/GEP20094614B/en unknown
- 2002-10-28 PL PL02369790A patent/PL369790A1/xx not_active IP Right Cessation
- 2002-10-28 ES ES06024500T patent/ES2336238T3/es not_active Expired - Lifetime
- 2002-10-28 AT AT06024500T patent/ATE451123T1/de active
- 2002-10-28 PE PE2002001058A patent/PE20030692A1/es not_active Application Discontinuation
- 2002-10-28 MY MYPI20024018A patent/MY149482A/en unknown
- 2002-10-28 PL PL402549A patent/PL402549A1/pl not_active Application Discontinuation
- 2002-10-28 DK DK06024500.8T patent/DK1764111T3/da active
- 2002-10-28 AT AT02785326T patent/ATE346614T1/de active
- 2002-10-28 SI SI200230452T patent/SI1441770T1/sl unknown
- 2002-10-28 BR BR0213585-0A patent/BR0213585A/pt active Search and Examination
- 2002-10-28 SI SI200230886T patent/SI1764111T1/sl unknown
- 2002-10-28 PT PT02785326T patent/PT1441770E/pt unknown
- 2002-10-28 AR ARP020104079A patent/AR037048A1/es unknown
- 2002-10-28 CN CNB028215656A patent/CN100404072C/zh not_active Expired - Fee Related
- 2002-10-28 RU RU2008133235/15A patent/RU2476212C2/ru not_active IP Right Cessation
- 2002-10-28 NZ NZ532295A patent/NZ532295A/en not_active IP Right Cessation
- 2002-10-28 EP EP02785326A patent/EP1441770B1/en not_active Expired - Lifetime
- 2002-10-28 EP EP06024500A patent/EP1764111B1/en not_active Expired - Lifetime
- 2002-10-28 ES ES02785326T patent/ES2275928T3/es not_active Expired - Lifetime
- 2002-10-28 RU RU2004116346/15A patent/RU2345758C2/ru not_active IP Right Cessation
- 2002-10-28 UA UA20040403211A patent/UA90077C2/uk unknown
- 2002-10-28 DK DK02785326T patent/DK1441770T3/da active
- 2002-10-28 MY MYPI2010004778A patent/MY145215A/en unknown
- 2002-10-28 CA CA2465132A patent/CA2465132C/en not_active Expired - Fee Related
- 2002-10-28 KR KR1020047006271A patent/KR20050040820A/ko not_active Application Discontinuation
- 2002-10-28 DE DE60216495T patent/DE60216495T2/de not_active Expired - Lifetime
- 2002-10-28 ME MEP-2008-349A patent/ME00255B/me unknown
- 2002-10-28 KR KR1020107016839A patent/KR20100088718A/ko not_active Application Discontinuation
- 2002-10-28 DE DE60234725T patent/DE60234725D1/de not_active Expired - Lifetime
- 2002-10-28 MX MXPA04003976A patent/MXPA04003976A/es active IP Right Grant
- 2002-10-28 HU HU0402389A patent/HUP0402389A3/hu unknown
- 2002-10-28 JP JP2003539721A patent/JP2005511564A/ja active Pending
- 2002-10-28 PT PT06024500T patent/PT1764111E/pt unknown
- 2002-10-28 IL IL16151302A patent/IL161513A0/xx unknown
- 2002-10-28 AU AU2002350644A patent/AU2002350644B2/en not_active Ceased
-
2004
- 2004-04-19 ZA ZA2004/02944A patent/ZA200402944B/en unknown
- 2004-04-19 IL IL161513A patent/IL161513A/en not_active IP Right Cessation
- 2004-04-29 MA MA27663A patent/MA26230A1/fr unknown
- 2004-05-27 HR HR20040479A patent/HRP20040479B1/xx not_active IP Right Cessation
- 2004-05-28 NO NO20042208A patent/NO333544B1/no not_active IP Right Cessation
- 2004-08-13 HK HK04106073A patent/HK1063293A1/xx not_active IP Right Cessation
-
2007
- 2007-02-09 CY CY20071100173T patent/CY1106000T1/el unknown
- 2007-09-20 HK HK07110257.0A patent/HK1102221A1/xx not_active IP Right Cessation
-
2010
- 2010-02-25 CY CY20101100180T patent/CY1110288T1/el unknown
-
2011
- 2011-02-17 IL IL211288A patent/IL211288A/en not_active IP Right Cessation
- 2011-05-31 JP JP2011121273A patent/JP2011201909A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20030692A1 (es) | Agentes antidisritmicos administrados vaginalmente para tratar el dolor pelvico | |
AR019916A1 (es) | Uso de 11-(3-dimetilaminopropiliden)-6,11-dihidrobenz[b,e]oxepin-2-acetico para la manufactura de una formulacion farmaceutica oftalmica util para eltratamiento o prevencion de la neovascularizacion ocular y trastornos inflamatorios oftalmicos no alergicos que involucran la liberacion de citoquinas | |
DE60141145D1 (es) | ||
DK0538443T3 (da) | Fremgangsmåde og formuleringer til kontraception og til behandling af godartede gynækologiske forstyrrelser | |
BR0112571A (pt) | Método para o tratamento de fêmeas humanas, composição farmaceuticamente aceitável e dispositivo para aplicação intravaginal ou transvaginal de um agente farmacêutico antifúngico, antiviral, antibacteriano ou parasiticida | |
AR021738A1 (es) | Uso de neurotoxinas para preparar composiciones para aliviar el dolor, de administracion intraespinal | |
CO5680109A1 (es) | Compuestos para el tratamiento de la disfuncion sexual femenina | |
PT969813E (pt) | Composicao farmaceutica topica compreendendo um agente colinergico ou um bloqueador de canal de calcio | |
CL2004000119A1 (es) | Composicion farmaceutica que comprende un agonista/antagonista de estrogenos definido y un secretagogo de la hormona del crecimiento, util para tratar una condicion que se presenta con una masa osea reducida. | |
CO5310576A1 (es) | Compuestos heterocilcicos como ligandos de los receptores gabaa | |
AR027234A1 (es) | Derivados de la toxina clostridial y metodos para el tratamiento del dolor | |
AR016667A1 (es) | Uso de una combinacion de un antiestrogeno mas progestina para la preparacion de un medicamento util para proveer la anticoncepcion y un kit deanticonceptivos adaptados para la administracion oral diaria | |
HRP20040480B1 (en) | Lox concentration of peroxide for treating or preventing vaginal infections | |
HK1059738A1 (en) | Methods and pharmaceutical compositions for healing wounds | |
MD20020075A (en) | Antimicrobial preparation with retarded release of the biologically active component, utilization thereof and process for implant obtaining | |
ES2184145T3 (es) | Compuestos de acido sulfonico o sulfonilamino-n-(heteroaralquil)-azaheterociclilamida. | |
PE20011079A1 (es) | Derivados de acido 1,2,3,4-tetrahidroquinolin-2-carboxilico sustituidos, procedimientos para su preparacion, y composiciones que los comprenden | |
HRP20030907B1 (en) | Pharmaceutical composition based on macrolides for topical application in ophthalmology | |
ES2113533T3 (es) | Composiciones farmaceuticas de alquilsulfonamidas agonistas de 5-ht1 para administracion rectal. | |
WO2003034998A3 (en) | Composition and method for treating erectile dysfunction and reducing fibrosis in erectile tissue of the human penis | |
CO5580798A2 (es) | Composicion de peroxido de liberacion prolongada para infecciones vaginales | |
AR044184A1 (es) | Metodo para el manejo terapeutico de la proliferacion extrauterina de tejido endometrial, dolor pelvico cronico y obstruccion de las trompas de falopio, las composiciones farmaceuticas utiles para la aplicacion de dicho metodo y el uso de un antagonista de lhrh para la preparacion de dichos medicame | |
UA95691C2 (ru) | Фармацевтическая вагинальная композиция и ее применение | |
ECSP22067445A (es) | Composición farmacéutica adecuada para la administración vaginal | |
BR0208965A (pt) | Uso de uma solução de irrigação de canal contendo um agente espermicida, procedimento de vasectomia, kit para uso em uma irrigação de canal associada com um procedimento de vasectomia, e, solução de irrigação de canal. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |